Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Glycosylation at 11Asn on hemagglutinin of H5N1 influenza virus contributes to its biological characteristics.

Yin Y, Zhang X, Qiao Y, Wang X, Su Y, Chen S, Qin T, Peng D, Liu X.

Vet Res. 2017 Nov 21;48(1):81. doi: 10.1186/s13567-017-0484-8.

2.

Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.

Kazaks A, Lu IN, Farinelle S, Ramirez A, Crescente V, Blaha B, Ogonah O, Mukhopadhyay T, de Obanos MP, Krimer A, Akopjana I, Bogans J, Ose V, Kirsteina A, Kazaka T, Stonehouse NJ, Rowlands DJ, Muller CP, Tars K, Rosenberg WM.

BMC Biotechnol. 2017 Nov 10;17(1):79. doi: 10.1186/s12896-017-0396-8.

3.

Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.

Maamary J, Wang TT, Tan GS, Palese P, Ravetch JV.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10172-10177. doi: 10.1073/pnas.1707950114. Epub 2017 Sep 5.

PMID:
28874545
4.

Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses.

Moon HJ, Nikapitiya C, Lee HC, Park ME, Kim JH, Kim TH, Yoon JE, Cho WK, Ma JY, Kim CJ, Jung JU, Lee JS.

Sci Rep. 2017 Jul 7;7(1):4875. doi: 10.1038/s41598-017-04777-4.

5.

Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang X, Xu J, Kent SJ.

JCI Insight. 2017 Jul 6;2(13). pii: 92750. doi: 10.1172/jci.insight.92750. [Epub ahead of print]

6.

In Vivo Imaging of Influenza Virus Infection in Immunized Mice.

Czakó R, Vogel L, Lamirande EW, Bock KW, Moore IN, Ellebedy AH, Ahmed R, Mehle A, Subbarao K.

MBio. 2017 May 30;8(3). pii: e00714-17. doi: 10.1128/mBio.00714-17.

7.

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.

Rajendran M, Nachbagauer R, Ermler ME, Bunduc P, Amanat F, Izikson R, Cox M, Palese P, Eichelberger M, Krammer F.

MBio. 2017 Mar 21;8(2). pii: e02281-16. doi: 10.1128/mBio.02281-16.

8.

Universal influenza virus vaccines and therapeutic antibodies.

Nachbagauer R, Krammer F.

Clin Microbiol Infect. 2017 Apr;23(4):222-228. doi: 10.1016/j.cmi.2017.02.009. Epub 2017 Feb 12. Review.

PMID:
28216325
9.

Immune history and influenza virus susceptibility.

Cobey S, Hensley SE.

Curr Opin Virol. 2017 Feb;22:105-111. doi: 10.1016/j.coviro.2016.12.004. Epub 2017 Jan 12. Review.

PMID:
28088686
10.
11.

Genome-wide analyses reveal a highly conserved Dengue virus envelope peptide which is critical for virus viability and antigenic in humans.

Fleith RC, Lobo FP, Dos Santos PF, Rocha MM, Bordignon J, Strottmann DM, Patricio DO, Pavanelli WR, Lo Sarzi M, Santos CN, Ferguson BJ, Mansur DS.

Sci Rep. 2016 Nov 2;6:36339. doi: 10.1038/srep36339.

12.

A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.

Ramakrishnan B, Viswanathan K, Tharakaraman K, Dančík V, Raman R, Babcock GJ, Shriver Z, Sasisekharan R.

Trends Microbiol. 2016 Dec;24(12):933-943. doi: 10.1016/j.tim.2016.09.003. Epub 2016 Oct 14. Review.

13.

Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.

Gaiotto T, Hufton SE.

PLoS One. 2016 Oct 14;11(10):e0164296. doi: 10.1371/journal.pone.0164296. eCollection 2016.

14.

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.

Leon PE, He W, Mullarkey CE, Bailey MJ, Miller MS, Krammer F, Palese P, Tan GS.

Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5944-E5951. Epub 2016 Sep 19.

15.

Selection of antigenically advanced variants of seasonal influenza viruses.

Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, Iwatsuki-Horimoto K, Russell CA, James SL, Skepner E, Maher EA, Neumann G, Klimov AI, Kelso A, McCauley J, Wang D, Shu Y, Odagiri T, Tashiro M, Xu X, Wentworth DE, Katz JM, Cox NJ, Smith DJ, Kawaoka Y.

Nat Microbiol. 2016 May 23;1(6):16058. doi: 10.1038/nmicrobiol.2016.58.

16.
17.

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.

Kallewaard NL, Corti D, Collins PJ, Neu U, McAuliffe JM, Benjamin E, Wachter-Rosati L, Palmer-Hill FJ, Yuan AQ, Walker PA, Vorlaender MK, Bianchi S, Guarino B, De Marco A, Vanzetta F, Agatic G, Foglierini M, Pinna D, Fernandez-Rodriguez B, Fruehwirth A, Silacci C, Ogrodowicz RW, Martin SR, Sallusto F, Suzich JA, Lanzavecchia A, Zhu Q, Gamblin SJ, Skehel JJ.

Cell. 2016 Jul 28;166(3):596-608. doi: 10.1016/j.cell.2016.05.073. Epub 2016 Jul 21.

18.

A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity.

Stepanova LA, Sergeeva MV, Shuklina MA, Shaldzhyan AA, Potapchuk MV, Korotkov AV, Tsybalova LM.

Acta Naturae. 2016 Apr-Jun;8(2):116-26.

19.

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.

Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS, Kent SJ.

EBioMedicine. 2016 Jun;8:277-290. doi: 10.1016/j.ebiom.2016.04.029. Epub 2016 Apr 28.

20.

Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Neu KE, Henry Dunand CJ, Wilson PC.

Curr Opin Immunol. 2016 Oct;42:48-55. doi: 10.1016/j.coi.2016.05.012. Epub 2016 Jun 3. Review.

Supplemental Content

Support Center